Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Nephrology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
EMJ Nephrology 11.1 2023
July 2023
We are delighted to share the latest issue of EMJ Nephrology with you, featuring peer-reviewed articles, as well as insightful interviews with esteemed experts in the field.
Read more
August 2023
EMJ Nephrology 11 [Supplement 1] 2023
This article was funded by Sanofi and is intended for healthcare professionals.
July 2023
EMJ Nephrology 11.1 2023
We are delighted to share the latest issue of EMJ Nephrology with you, featuring peer-reviewed articles, as well as insightful interviews with esteemed experts in the field.
November 2022
EMJ Nephrology 10 [Infographic 3] 2022
This infographic explores a contemporary strategy to decrease the risk of cardiovascular disease and mortality associated with end-stage kidney disease (ESKD).
November 2022
EMJ Nephrology 10 [Infographic 2] 2022
This infographic explores the epidemiology, burden, and unmet need in IgA nephropathy (IgAN). Delving into the pathophysiology of IgAN, the infographic breaks down the different aspects of the kidney that are impacted by the inflammatory mediators endothelin-1 and angiotensin II.
June 2022
EMJ Nephrology 10.1 2022
Sharing key updates in the field in the form of reviews and research articles, our latest release features insights into COVID-19-associated nephropathy, diabetic kidney disease, and perspectives on the use of sodium-glucose co-transporter inhibitors in kidney disease.
March 2022
EMJ Nephrology 10 [Supplement 1] 2022
In an interview conducted by EMJ, leading experts from the field of nephrology and renal medicine discussed the high mortality rates in patients on long-term haemodialysis (HD), despite the recent developments in treatment.
November 2021
EMJ Nephrology 9 [Supplement 4] 2021
CHRONIC kidney disease (CKD) affects approximately 700 million individuals worldwide. Many patients with CKD require haemodialysis, and more than two-thirds of these patients have CKD-associated pruritus (CKD-aP). CKD-aP can be bothersome for many patients and drastically affect quality of life, from causing sleep issues to mental health problems. Almost 40% of dialysis patients are at least ‘moderately’ bothered and 19% of patients are at least very much bothered by pruritus.
August 2021
EMJ Nephrology 9 [Supplement 3] 2021
PRURITUS is a common challenging symptom seen in chronic kidney disease (CKD). Approximately 40% of patients with end-stage renal…
Loading posts...
1
2
3
Next »